Inventor · disambiguated record
Gilles Bernard Tremblay
Also filed as: TREMBLAY GILLES · TREMBLAY GILLES BERNARD
28 granted patents·14 pending applications·134 citations·filing 2005–2024
96Inventor score
Files withALETHIA BIOTHERAPEUTICS INC13SOOKNANAN ROY RABINDRANAUTH8ADC THERAPEUTICS SA6TREMBLAY GILLES BERNARD6DAIICHI SANKYO CO LTD5
Top patents by PatentIndex Score
42 records- 0195US7989160B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2007·Granted Aug 2, 2011·25 cites·34 claims
- 0293US8168181B2Methods of impairing osteoclast differentiation using antibodies that bind siglec-15SOOKNANAN ROY RABINDRANAUTH·Filed 2009·Granted May 1, 2012·15 cites·25 claims
- 0392US8540988B2Antibodies that bind polypeptides involved in the process of bone remodelingSOOKNANAN ROY RABINDRANAUTH·Filed 2011·Granted Sep 24, 2013·13 cites·19 claims
- 0492US8431126B2Antibodies that bind polypeptides involved in the process of bone remodelingSOOKNANAN ROY RABINDRANAUTH·Filed 2012·Granted Apr 30, 2013·13 cites·13 claims
- 0590US8580257B2Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)TREMBLAY GILLES BERNARD·Filed 2011·Granted Nov 12, 2013·13 cites·20 claims
- 0688US9067984B2Methods of impairing osteoclast differentiation using antibodies that bind Siglec-15ALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 30, 2015·6 cites·13 claims
- 0788US8216582B2Polynucleotides and polypeptide sequences involved in cancerSOOKNANAN ROY RABINDRANAUTH·Filed 2007·Granted Jul 10, 2012·9 cites·15 claims
- 0887US8900579B2Siglec-15 antibodies in treating bone loss-related diseaseALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 2, 2014·8 cites·20 claims
- 0985US11945856B2Activin receptor type IIB variants and uses thereof35PHARMA INC·Filed 2023·Granted Apr 2, 2024·1 cites·33 claims
- 1085US9393302B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 19, 2016·5 cites·20 claims
- 1185US8937163B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofTREMBLAY GILLES BERNARD·Filed 2012·Granted Jan 20, 2015·6 cites·20 claims
- 1284US9828426B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2016·Granted Nov 28, 2017·3 cites·21 claims
- 1381US8802826B2Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeTREMBLAY GILLES BERNARD·Filed 2010·Granted Aug 12, 2014·4 cites·14 claims
- 1479US8741289B2Siglec 15 antibodies in treating bone loss-related diseaseTREMBLAY GILLES BERNARD·Filed 2010·Granted Jun 3, 2014·3 cites·21 claims
- 1578US9388242B2Nucleic acids encoding anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·2 cites·20 claims
- 1676US9493562B2Anti-Siglec-15 antibodiesALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 15, 2016·3 cites·14 claims
- 1775US9695419B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingDAIICHI SANKYO CO LTD·Filed 2015·Granted Jul 4, 2017·1 cites·5 claims
- 1875US9617337B2Siglec-15 antibodies in treating bone loss-related diseaseDAIICHI SANKYO CO LTD·Filed 2016·Granted Apr 11, 2017·1 cites·22 claims
- 1975US9040246B2Methods of making antibodies that bind polypeptides involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted May 26, 2015·1 cites·9 claims
- 2074US9855291B2Anti-kidney associated antigen 1 (KAAG1) antibodiesTREMBLAY GILLES BERNARD·Filed 2009·Granted Jan 2, 2018·1 cites·14 claims
- 2174US7947436B2Polynucleotides and polypeptide sequences involved in the process of bone remodelingALETHIA BIOTHERAPEUTICS INC·Filed 2005·Granted May 24, 2011·1 cites·31 claims
- 2274US2021054067A1Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 2373US12421296B2Activin receptor type IIB variants and uses thereof35PHARMA INC·Filed 2024·Granted Sep 23, 2025·0 cites·28 claims
- 2467USRE47672EMethods of impairing osteoclast differentiation using antibodies that bind siglec-15DAIICHI SANKYO CO LTD·Filed 2017·Granted Oct 29, 2019·0 cites·26 claims
- 2563US2017260529A1Polynucleotides and polypeptide sequences involved in the process of bone remodelingDAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
- 2662US11084872B2Method for treating breast cancerADC THERAPEUTICS SA·Filed 2018·Granted Aug 10, 2021·0 cites·23 claims
- 2762US10597450B2Antibodies against kidney associated antigen 1 and antigen binding fragments thereofADC THERAPEUTICS SA·Filed 2017·Granted Mar 24, 2020·0 cites·70 claims
- 2862US9512211B2Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeALETHIA BIOTHERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·0 cites·8 claims
- 2962US2024254195A1Activin receptor type iib variants and uses thereof35PHARMA INC·Filed 2023·Application pending·0 cites
- 3059US8444975B2Method for inhibiting bone resorptionSOOKNANAN ROY RABINDRANAUTH·Filed 2012·Granted May 21, 2013·0 cites·16 claims
- 3159US2018346563A1Polynucleotides and polypeptide sequences involved in cancerADC THERAPEUTICS SA·Filed 2018·Application pending·0 cites
- 3257US2012288498A1Polynucleotides and polypeptide sequences involved in cancerSOOKNANAN ROY RABINDRANAUTH·Filed 2012·Application pending·0 cites
- 3355US2018369269A1Antibodies that specifically block the biological activity of a tumor antigenADC THERAPEUTICS SA·Filed 2017·Application pending·0 cites
- 3453US2023340048A1Transforming growth factor beta (tgfbeta) binding agents and uses thereofBRISTOL MYERS SQUIBB TGF BETA INC·Filed 2021·Application pending·0 cites
- 3552US2017233487A1Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor VolumeALETHIA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3652US2011286924A1Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancerTREMBLAY GILLES BERNARD·Filed 2008·Application pending·0 cites
- 3751US2016039930A1Polynucleotides and polypeptide sequences involved in cancerALETHIA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3851US2011293604A1Polynucleotides and polypeptide sequences involved in the process of bone remodelingSOOKNANAN ROY RABINDRANAUTH·Filed 2011·Application pending·0 cites
- 3949US2017174753A1Method for treating breast cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4047US9822170B2Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancerALETHIA BIOTHERAPEUTICS INC·Filed 2013·Granted Nov 21, 2017·0 cites·17 claims
- 4142US2012128661A1Polynucleotide and polypeptide sequences involved in cancerSOOKNANAN ROY RABINDRANAUTH·Filed 2011·Application pending·0 cites
- 4234US2017129956A1Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfectaDAIICHI SANKYO CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gilles Bernard Tremblay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →